Iu B Lishmanov Selected Research

DuP 734

11/2000	[Anti-arrhythmic effect of the sigma-receptor blocker DuP 734 in ischemia and myocardial reperfusion].
9/2000	[The use of delta-receptor antagonist DuP 734 for correction of the contractile diastolic cardiac dysfunction in reperfusion injury and oxidative stress].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Iu B Lishmanov Research Topics

Disease

22	Ischemia 01/2012 - 02/2000
6	Cardiac Arrhythmias (Arrythmia) 11/2004 - 03/2000
5	Hypoxia (Hypoxemia) 01/2012 - 01/2003
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2015 - 01/2003
4	Infarction (Infarctions) 07/2006 - 01/2001
3	Reperfusion Injury 01/2013 - 02/2000
3	Thromboembolism 01/2011 - 01/2007
2	Coronary Disease (Coronary Heart Disease) 01/2011 - 01/2002
2	Myocardial Stunning (Stunned Myocardium) 03/2004 - 09/2000
2	Ventricular Fibrillation 01/2002 - 01/2001
1	Heart Arrest (Cardiac Arrest) 01/2015
1	Chronic Obstructive Pulmonary Disease (COPD) 11/2013
1	Shock 07/2013
1	Heart Diseases (Heart Disease) 01/2012
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2012
1	Myocarditis (Carditis) 01/2011
1	Ventricular Tachycardia 01/2011
1	Ventricular Premature Complexes (Premature Ventricular Contraction) 01/2011
1	Myocardial Infarction 03/2008
1	Hypertension (High Blood Pressure) 01/2008
1	Cardio-Renal Syndrome 01/2008
1	Cognitive Dysfunction 01/2008
1	Heart Failure 01/2008
1	Essential Hypertension 01/2006
1	Heart Injuries 03/2005
1	Contracture 03/2004
1	Coronary Occlusion 11/2003
1	Coronary Restenosis 01/2003
1	Pathologic Constriction (Stenosis) 01/2003
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2002
1	Narcotic-Related Disorders 09/2001
1	Ganglion Cysts (Ganglion) 05/2001

Drug/Important Bio-Agent (IBA)

6	Radioisotopes (Radionuclides)IBA 11/2013 - 01/2008
5	Opioid Analgesics (Opioids)IBA 01/2012 - 02/2000
5	Opioid Receptors (Opioid Receptor)IBA 04/2007 - 05/2001
5	D-Penicillamine (2,5)- EnkephalinIBA 10/2006 - 01/2002
5	sigma Receptors (sigma Receptor)IBA 03/2004 - 03/2000
4	SolutionsIBA 01/2012 - 11/2000
3	Creatine Kinase (Creatine Phosphokinase)IBA 01/2012 - 03/2004
3	HU 211 (HU 210)IBA 01/2012 - 05/2001
3	Adenosine Triphosphate (ATP)IBA 04/2008 - 01/2002
3	Ala(2)-Arg(6)- enkephalin-LeuIBA 03/2008 - 01/2002
3	delta Opioid Receptors (delta Opioid Receptor)IBA 10/2006 - 09/2000
2	Peptides (Polypeptides)IBA 01/2012 - 01/2002
2	kappa(1) opioid receptorIBA 09/2008 - 03/2008
2	ChloraloseIBA 05/2008 - 11/2004
2	ORALIT (ORS)IBA 03/2008 - 11/2003
2	Nociceptin ReceptorIBA 07/2006 - 11/2004
2	Hexamethonium (Hexamethonium Bromide)IBA 11/2004 - 05/2001
2	AconitineIBA 11/2004 - 05/2001
2	Anti-Arrhythmia AgentsIBA 09/2001 - 11/2000
2	LigandsIBA 01/2001 - 03/2000
2	DuP 734IBA 11/2000 - 09/2000
1	Endothelin-1 (Endothelin 1)IBA 11/2013
1	Antihypertensive Agents (Antihypertensives)IBA 01/2012
1	Mitochondrial Uncoupling ProteinsIBA 08/2011
1	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2011
1	AntibodiesIBA 01/2011
1	Triethylenephosphoramide (TEPA)IBA 01/2011
1	Aldehyde Reductase (Aldose Reductase)IBA 05/2010
1	Proteins (Proteins, Gene)FDA Link 05/2010
1	MicroRNAs (MicroRNA)IBA 05/2010
1	GinsenosidesIBA 09/2008
1	HomocysteineIBA 09/2008
1	Pharmaceutical PreparationsIBA 05/2008
1	mu Opioid Receptors (mu Opioid Receptor)IBA 03/2008
1	RadiopharmaceuticalsIBA 01/2007
1	TAN 67IBA 10/2006
1	ProstaglandinsIBA 03/2005
1	Ether (Diethyl Ether)IBA 11/2004
1	NociceptinIBA 11/2004
1	destyrosyl- dalarginIBA 07/2004
1	Calcium Gluconate (CBG)IBA 01/2004
1	tyrosyl-arginyl-phenylalanyl-lysinamide (DALDA)IBA 11/2003
1	Potassium Channels (Potassium Channel)IBA 11/2003
1	KATP ChannelsIBA 11/2003
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 09/2003
1	tyrosyl- tetrahydroisoquinolinecarbonyl- psi(methylamino)phenylalanyl- phenylalanineIBA 01/2003
1	Narcotic Antagonists (Opioid Antagonists)IBA 01/2003
1	Thallium-199IBA 01/2003
1	LipidsIBA 01/2002
1	Oxygen (Dioxygen)IBA 01/2002
1	Neprilysin (Neutral Endopeptidase)IBA 09/2001
1	Opiate AlkaloidsIBA 09/2001
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 05/2001
1	Epinephrine (Adrenaline)FDA LinkGeneric 05/2001
1	CannabinoidsIBA 05/2001
1	RimonabantIBA 05/2001
1	kappa Opioid Receptors (kappa Opioid Receptor)IBA 01/2001
1	Ala(2)-MePhe(4)-Gly(5)- Enkephalin (DAGO)IBA 02/2000

Therapy/Procedure

4	Therapeutics 01/2012 - 01/2006
4	Intravenous Administration 03/2008 - 01/2003
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2015 - 01/2004
1	Extracorporeal Circulation 01/2015
1	Myocardial Revascularization 01/2015
1	Ischemic Postconditioning 01/2012
1	Sublingual Administration 01/2006
1	Injections 11/2004
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2004
1	Intravenous Injections 05/2002